A detailed history of Pier 88 Investment Partners LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 26,415 shares of ADPT stock, worth $95,358. This represents 0.13% of its overall portfolio holdings.

Number of Shares
26,415
Previous 24,795 6.53%
Holding current value
$95,358
Previous $121,000 30.58%
% of portfolio
0.13%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.88 - $4.8 $4,665 - $7,776
1,620 Added 6.53%
26,415 $84,000
Q4 2023

Feb 09, 2024

SELL
$3.46 - $5.33 $178,882 - $275,561
-51,700 Reduced 67.59%
24,795 $121,000
Q3 2023

Nov 09, 2023

BUY
$5.07 - $8.44 $24,690 - $41,102
4,870 Added 6.8%
76,495 $416,000
Q1 2023

May 09, 2023

BUY
$7.8 - $10.11 $112,476 - $145,786
14,420 Added 25.21%
71,625 $632,000
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $12,610 - $24,579
1,940 Added 3.51%
57,205 $407,000
Q2 2022

Aug 12, 2022

BUY
$6.4 - $14.73 $215,424 - $495,811
33,660 Added 155.8%
55,265 $447,000
Q1 2022

May 13, 2022

SELL
$10.12 - $28.9 $110,004 - $314,143
-10,870 Reduced 33.47%
21,605 $300,000
Q4 2021

Feb 14, 2022

BUY
$25.17 - $36.85 $353,638 - $517,742
14,050 Added 76.26%
32,475 $911,000
Q3 2021

Nov 12, 2021

SELL
$30.02 - $39.87 $310,316 - $412,136
-10,337 Reduced 35.94%
18,425 $626,000
Q2 2021

Aug 13, 2021

BUY
$32.22 - $44.59 $383,418 - $530,621
11,900 Added 70.57%
28,762 $1.18 Million
Q1 2021

May 14, 2021

SELL
$37.26 - $67.74 $41,358 - $75,191
-1,110 Reduced 6.18%
16,862 $679,000
Q4 2020

Feb 12, 2021

SELL
$45.01 - $65.47 $300,216 - $436,684
-6,670 Reduced 27.07%
17,972 $3.31 Million
Q3 2020

Nov 16, 2020

BUY
$35.79 - $48.81 $419,888 - $572,638
11,732 Added 90.88%
24,642 $1.2 Million
Q2 2020

Aug 14, 2020

BUY
$24.95 - $48.38 $322,104 - $624,585
12,910 New
12,910 $625,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $516M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.